Invention Grant
- Patent Title: Synthesis of omecamtiv mecarbil
-
Application No.: US16607940Application Date: 2018-06-29
-
Publication No.: US11040956B2Publication Date: 2021-06-22
- Inventor: Sebastien Caille , Kyle Quasdorf , Philipp Roosen , Xianqing Shi , Andrew Cosbie , Fang Wang , Zufan Wu , Archana Neergunda , Bin Peter Quan , Lianxiu Guan
- Applicant: AMGEN INC.
- Applicant Address: US CA Thousand Oaks
- Assignee: AMGEN INC.
- Current Assignee: AMGEN INC.
- Current Assignee Address: US CA Thousand Oaks
- Agency: Marshall, Gerstein & Borun LLP
- International Application: PCT/US2018/040176 WO 20180629
- International Announcement: WO2019/006231 WO 20190103
- Main IPC: C07D295/205
- IPC: C07D295/205 ; C07D213/75 ; C07D401/12 ; C07D241/04
Abstract:
Provided herein is a synthesis for omecamtiv mecarbil dihydrochloride hydrate and various intermediates. (I)
Public/Granted literature
- US20200308143A1 SYNTHESIS OF OMECAMTIV MECARBIL Public/Granted day:2020-10-01
Information query
